Intellia Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of NTLA for the last quarter is -1.92 M USD, and it's 115.99% lower compared to the previous quarter. The net income of Q4 23 is -132.16 M USD.